American Journal of Nephrology

Papers
(The H4-Index of American Journal of Nephrology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy257
Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ Damage74
Nephrotoxicity from Vancomycin Combined with Piperacillin-Tazobactam: A Comprehensive Review51
Aldosterone and Mineralocorticoid Receptor Signaling as Determinants of Cardiovascular and Renal Injury: From Hans Selye to the Present41
Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial37
Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents34
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome29
Starvation Ketosis and the Kidney29
New Onset Biopsy-Proven Nephropathies after COVID Vaccination28
Direct Blood Pressure-Independent Anti-Fibrotic Effects by the Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone in Progressive Models of Kidney Fibrosis28
The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease26
Machine Learning for Prediction and Risk Stratification of Lupus Nephritis Renal Flare25
Efficacy and Safety of Molidustat for Anemia in ESA-Naive Nondialysis Patients: A Randomized, Phase 3 Trial24
The Forgotten Antiproteinuric Properties of Diuretics22
Molidustat for Renal Anemia in Nondialysis Patients Previously Treated with Erythropoiesis-Stimulating Agents: A Randomized, Open-Label, Phase 3 Study21
Genetic Etiologies for Chronic Kidney Disease Revealed through Next-Generation Renal Gene Panel18
Dyslipidemia in Chronic Kidney Disease: Contemporary Concepts and Future Therapeutic Perspectives17
0.021158933639526